Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | NR5A2 | O00482 | 1/20 | 1.00 |
| ▸ | NR5A1 | Q13285 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.88 |
| ▸ | FABP3 | P05413 | 1/20 | 0.78 |
| ▸ | RECQL | P46063 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.66 |
| ▸ | PTAFR | P25105 | 1/20 | 0.66 |
| ▸ | HTR1D | P28221 | 1/20 | 0.66 |
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.66 |
| ▸ | DRD3 | P35462 | 1/20 | 0.66 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.66 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.63 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.63 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | GMNN | O75496 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL235513 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| Colfosceril Palmitate SCHEMBL184776 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL233979 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL234757 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL22693933 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL17165029 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL237094 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL2135188 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL233582 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL235645 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12599605-B2 | Uric acid liposomes | HOSPITAL CLINIC DE BARCELONA (ES) | 2026-04-14 | — | — | US | claimed |
| US-20250360200-A1 | VACCINE COMPOSITIONS AND USES THEREOF | UNIV MICHIGAN REGENTS (US) | 2025-11-27 | — | — | US | claimed |
| CN-120009446-A | Lipidomic method for distinguishing green tea of different varieties | 中南民族大学 | 2025-05-16 | — | — | CN | claimed |
| EP-4531931-A1 | VACCINE COMPOSITIONS AND USES THEREOF | The Regents of The University of Michigan (US) | 2025-04-09 | — | — | EP | claimed |
| US-20240390381-A1 | URIC ACID LIPOSOMES | AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS, M.P. (ES) | 2024-11-28 | — | — | US | claimed |
| US-20240382626-A1 | IRRADIATION AMENABLE LIPOSOMAL DYE AGGREGATES AND METHODS OF SYNTHESIS AND USE THEREOF | UNIV TEXAS (US) | 2024-11-21 | — | — | US | claimed |
| CN-113848261-B | Identification method of fungi based on lipidomic | 中南民族大学 | 2024-08-27 | — | — | CN | claimed |
| US-20240180868-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VIRUS INFECTION, THE PHARMACEUTICAL COMPOSITION COMPRISING ROTTLERIN AS ACTIVE INGREDIENT | QVET (KR) | 2024-06-06 | — | — | US | claimed |
| WO-2024053974-A1 | COMPOSITION FOR PHOTOTHERMAL THERAPY AND PREPARATION METHOD THEREFOR | 서울대학교산학협력단 | 2024-03-14 | — | — | WO | claimed |
| EP-4321158-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTIONS, CONTAINING ROTTLERIN AS ACTIVE INGREDIENT | Qvet (KR) | 2024-02-14 | — | — | EP | claimed |
| EP-3285814-A1 | IMAGING OF TUMOR-ASSOCIATED MACROPHAGES | Memorial Sloan-Kettering Cancer Center (US) | 2018-02-28 | — | — | EP | claimed |
| US-20170319719-A1 | J-Aggregate Forming Nanoparticle | UNIVERSITY HEALTH NETWORK (CA) | 2017-11-09 | — | — | US | claimed |
| WO-2016186429-A1 | COMPOSITION FOR CANCER TREATMENT COMPRISING INDOCYANINE GREEN-LIPOSOME COMPOSITE | 고려대학교산학협력단 | 2016-11-24 | — | — | WO | claimed |
| WO-2016172146-A1 | IMAGING OF TUMOR-ASSOCIATED MACROPHAGES | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2016-10-27 | — | — | WO | claimed |
| US-20150359912-A1 | J-Aggregate Forming Nanoparticle | UNIVERSITY HEALTH NETWORK (CA) | 2015-12-17 | — | — | US | claimed |
| US-20070014842-A1 | Pharmaceutical liposomal compositions | ID BIOMEDICAL CORPORATION OF QUEBEC C.O.B. AS GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA (CA) | 2007-01-18 | — | — | US | claimed |
| US-20070014841-A1 | Pharmaceutical compositions | ID BIOMEDICAL CORPORATION OF QUEBEC C.O.B. AS GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA (CA) | 2007-01-18 | — | — | US | claimed |
| EP-1536831-A2 | PHARMACEUTICAL LIPOSOMAL COMPOSITIONS CONTAINING N. MENINGITIDIS DERIVED POLYPEPTIDES OR POLYNUCLEOTIDES | ID Biomedical Corporation (CA) | 2005-06-08 | — | — | EP | claimed |
| US-20040132652-A1 | Pharmaceutical compositions | SHIRE BIOCHEM INC. (CA) | 2004-07-08 | — | — | US | claimed |
| WO-2004019976-A2 | PHARMACEUTICAL LIPOSOMAL COMPOSITIONS CONTAINING N. MENINGITIDIS DERIVED POLYPEPTIDES OR POLYNUCLEOTIDES | ID BIOMEDICAL CORPORATION (CA) | 2004-03-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014842-A1 | Pharmaceutical liposomal compositions | NGLY1, PHOSPHO1, LPXN | SMN1; SMN2 1933/4885NR5A2 2921/4885NR5A1 3363/4885 |
| US-12599605-B2 | Uric acid liposomes | CASP2, HTRA2, CASP10 | SMN1; SMN2 1112/4885NR5A2 4531/4885NR5A1 4842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.